Picture this: after months or even years of trying different antidepressants, adjusting doses, and sitting through therapy sessions that never quite moved the needle, you finally found something that worked. Your initial series of ketamine treatments lifted the fog. You felt like yourself again. Then, a few weeks later, you notice the familiar heaviness creeping back in. The question becomes: what now?
This is one of the most common moments we see at Delray Brain Science. Ketamine can produce remarkable results, but for many people, the initial series is just the beginning of the journey. That is where ketamine maintenance therapy comes in. It is the ongoing phase of care designed to sustain and build on the progress made during those first treatments, so that relief does not become just a brief window before symptoms return.
In this article, we want to walk you through exactly how ketamine maintenance therapy works, who tends to benefit most from it, what sessions actually look like on a practical level, and how we integrate it into a broader treatment plan here at our clinic. Whether you have already completed an initial ketamine series and are wondering about next steps, or you are just beginning to explore your options, this guide is meant to give you clear, honest information to help you make informed decisions about your care.
To understand why maintenance therapy matters, it helps to understand what makes ketamine so different from the medications most people have already tried.
Most traditional antidepressants, including SSRIs like sertraline and fluoxetine, and SNRIs like venlafaxine, work by adjusting levels of monoamine neurotransmitters. They target serotonin, norepinephrine, and sometimes dopamine. These medications can be effective, but they typically take weeks to build up in the system, and for a significant portion of people, they never produce adequate relief. That is the clinical definition of treatment-resistant depression: failing to respond to at least two different antidepressant trials at adequate doses.
Ketamine takes a completely different route. It works primarily on the glutamate system, which is the brain’s most abundant excitatory neurotransmitter network. Specifically, ketamine blocks a type of receptor called the NMDA receptor. When those receptors are blocked, it triggers a cascade of activity that increases a protein called brain-derived neurotrophic factor, or BDNF. Think of BDNF as a kind of fertilizer for the brain. It promotes synaptogenesis, which is the formation of new synaptic connections between neurons.
This is where the concept of neuroplasticity becomes central. Neuroplasticity refers to the brain’s ability to reorganize itself by forming new neural pathways. Chronic depression, trauma, and severe anxiety are associated with reduced neuroplasticity. Ketamine essentially jumpstarts that process, helping the brain rebuild connections that stress and illness have weakened or severed over time.
Here is the important part: those new connections need reinforcement to become stable. Just as physical therapy helps rebuild strength after an injury, repeated ketamine sessions during a maintenance phase help consolidate and sustain the neural changes initiated during the initial series.
The initial treatment series typically involves six to eight sessions delivered over two to four weeks. This concentrated phase is designed to produce a meaningful neurobiological shift. Maintenance therapy is what comes after, with sessions spaced further apart and calibrated to each patient’s individual response. It is not about starting over. It is about protecting and extending the progress already made.
We also offer SPRAVATO (esketamine), an FDA-cleared nasal spray form of ketamine that was approved in 2019 for treatment-resistant depression in adults. SPRAVATO is administered under medical supervision with a required observation period, and it can be an important option within a maintenance plan for appropriate patients. You can learn more about our ketamine and SPRAVATO treatment options on our services page.
Ketamine maintenance therapy is not a one-size-fits-all recommendation. We look at each patient’s history, diagnosis, and response to their initial series before discussing whether ongoing sessions make sense.
The patients who tend to benefit most share a few common characteristics. They responded meaningfully to their initial ketamine series, experiencing a real reduction in depressive symptoms, anxiety, or PTSD-related distress. But within weeks to a couple of months of completing that series, they notice symptoms beginning to return. This pattern of initial response followed by gradual symptom recurrence is one of the clearest indicators that maintenance therapy is worth exploring.
The conditions most commonly associated with a need for maintenance include:
Treatment-resistant depression: Patients who have not found lasting relief through multiple antidepressants and who responded well to ketamine often benefit from periodic booster sessions to maintain mood stability.
Chronic PTSD: Trauma-related symptoms can be deeply entrenched in the nervous system. Ketamine’s ability to promote neuroplasticity makes it a useful tool for ongoing trauma recovery, particularly when combined with therapy.
Bipolar depression: The depressive phases of bipolar disorder can be especially difficult to treat with standard medications. Some patients with bipolar depression find that ketamine maintenance, carefully coordinated with their overall psychiatric care, helps stabilize their mood over time.
Severe anxiety disorders: For patients with anxiety that has not responded to conventional treatments, ongoing ketamine sessions can provide a neurobiological foundation that supports other therapeutic work.
Beyond diagnosis, we also consider factors like the severity of the condition, the patient’s history of relapse with other treatments, and individual neurobiological response. Some people are simply faster metabolizers of ketamine’s effects, and their brain chemistry may require more frequent reinforcement than others. Understanding the specific ketamine treatment protocol used can also help patients set appropriate expectations for their maintenance journey.
It is equally important to be clear about who may not need maintenance therapy. Some patients complete their initial series and maintain strong remission for many months without any additional sessions. For those individuals, we monitor closely and only revisit the conversation if symptoms resurface. Others may be better served by a different modality entirely. Our TMS therapy or neurofeedback programs may provide more sustainable long-term support for certain patients, depending on their specific presentation and goals.
The goal is always to match the treatment to the person, not the other way around.
One of the most common questions we hear is: how often do maintenance sessions happen? The honest answer is that it varies, and that variability is intentional.
A typical maintenance schedule might begin with sessions every two to four weeks after the initial series concludes. As a patient stabilizes and demonstrates sustained improvement, we often extend the interval, moving toward monthly sessions and, in some cases, sessions every six to eight weeks or longer. The schedule is not fixed. It is a living plan that we adjust based on how each patient is doing.
We use a combination of patient-reported outcomes, mood tracking tools, and clinical assessments to guide those adjustments. If someone reports that their mood has remained stable and their sleep and concentration are holding steady, we may extend the interval between sessions. If they begin to notice early warning signs of symptom return, we may move the next session up. The patient’s own observations are a critical part of this process.
Here is what a single maintenance session generally looks like at our clinic. Before the infusion or SPRAVATO administration begins, we conduct a brief medical screening. This includes reviewing current medications, checking vital signs, and confirming there are no new contraindications that would affect treatment safety. This step is not a formality. It is a genuine clinical checkpoint.
The treatment itself, whether IV ketamine or SPRAVATO nasal spray, is administered in a calm, supervised setting. Patients are monitored throughout the session for vital signs, comfort, and any unexpected reactions. Sessions typically last between 40 minutes and two hours, depending on the treatment type, followed by a monitoring period before discharge.
Aftercare guidance is part of every session. Patients are advised not to drive for the remainder of the day, to arrange for someone to accompany them home, and to take it easy for the rest of the afternoon. Most people can return to their normal routine the following day.
We encourage patients to keep a simple mood journal between sessions. Techniques like cognitive brain training exercises between appointments can also complement the neuroplasticity benefits of ketamine and help patients maintain gains between sessions. The more information we have, the better we can calibrate the plan.
We want to be direct about something: ketamine maintenance therapy works best as one component of a comprehensive care plan, not as a standalone treatment. This is not a limitation of ketamine. It is a reflection of how complex and multifaceted mental health conditions actually are.
At Delray Brain Science, we take an integrated approach. For patients receiving ketamine maintenance, we typically coordinate that care with ongoing psychiatric evaluation and medication management. Ketamine does not replace psychiatric medications for most patients. Instead, it works alongside them, often enhancing the brain’s responsiveness to other treatments and creating a window of neuroplasticity during which therapy and lifestyle changes can take deeper root.
We also combine ketamine with other modalities when clinically appropriate. Neurofeedback, for example, uses EEG-based training to help patients regulate their own brain activity over time. Understanding how brain mapping works can help patients see why this kind of targeted approach is so valuable. Similarly, TMS therapy targets specific brain regions associated with mood regulation through magnetic stimulation, and it can work in parallel with a ketamine maintenance plan for certain patients.
Our psychiatric evaluation and medication management services ensure that every patient’s full clinical picture is reviewed regularly. Maintenance therapy is not a set-it-and-forget-it protocol. It requires active, ongoing clinical oversight.
Your role in this process matters. Honest symptom reporting, showing up to scheduled appointments, and staying in communication with your treatment team are the foundation of effective long-term care. Early signals are always easier to address than a full relapse.
Questions about long-term ketamine use are completely reasonable, and we welcome them. Here is what the evidence currently supports and what we do to keep patients safe throughout maintenance therapy.
During a ketamine session, the most common short-term side effects include dissociation (a sense of detachment from your surroundings or yourself), dizziness, nausea, elevated blood pressure, and sedation. These effects are temporary and typically resolve within a few hours of the session ending. In our clinical setting, we prepare patients for these experiences beforehand, monitor them throughout, and have protocols in place to manage any discomfort that arises.
The questions we hear most often about long-term use involve tolerance, dependency risk, and cognitive effects. Here is an honest summary of what we know:
Tolerance: Some patients do report that they need sessions more frequently over time to maintain the same level of benefit. This is something we monitor closely. If we observe signs of diminishing response, we reassess the overall treatment plan rather than simply increasing frequency indefinitely.
Dependency risk: Ketamine does have a potential for misuse, which is precisely why it should only be administered in a supervised clinical setting with appropriate screening and monitoring. When used responsibly within a structured maintenance program, the risk profile is meaningfully different from recreational use. The American Psychiatric Association has noted that ketamine and esketamine show promise for treatment-resistant depression while emphasizing the importance of careful patient selection and monitoring.
Cognitive effects: Long-term safety data is still being accumulated, and we are transparent with patients about that. Current evidence from clinical use does not indicate significant cognitive decline with appropriately spaced maintenance sessions. Patients concerned about cognitive health may also want to learn about the early signs of dementia so they can distinguish normal treatment side effects from more serious concerns. We conduct regular clinical assessments to watch for any changes in cognition or functioning.
Responsible maintenance therapy includes vital sign monitoring at every session, ongoing screening for contraindications, clear documentation of treatment response, and open communication between the patient and their care team. These are not optional extras. They are the standard of care we hold ourselves to at our clinic.
One of the patterns we see most often is patients waiting too long before reaching back out. After completing an initial ketamine series, it is natural to feel hopeful and to want to believe that the relief will hold indefinitely. Sometimes it does. But when it does not, the signs are often gradual and easy to rationalize away at first.
The signals worth paying attention to include a gradual return of low mood or emotional flatness over the weeks following your last session, disrupted sleep patterns that had previously improved, difficulty concentrating or making decisions, a resurgence of anxious thoughts or hypervigilance, and a general sense of losing the ground you had gained.
None of these signs means that ketamine failed. They often mean that your brain benefited from the initial series and is ready for continued support. For some patients, exploring how TMS works as a complementary approach can provide additional reinforcement alongside ketamine maintenance sessions.
Early intervention almost always produces better outcomes than waiting for a crisis. If you are unsure whether what you are experiencing warrants a conversation, err on the side of reaching out.
If you are unsure whether what you are experiencing warrants a conversation, err on the side of reaching out. That is what we are here for.
Ketamine maintenance therapy is not about becoming dependent on a treatment. It is about giving your brain the consistent, measured support it needs while it continues to heal and rebuild. For people with treatment-resistant depression, chronic PTSD, or severe mood disorders, that kind of sustained neurological support can make the difference between a brief period of relief and a genuinely transformed quality of life.
Some patients need sessions every few weeks for an extended period. Others transition to infrequent boosters and eventually step down entirely. What matters is that the plan is built around your specific response and clinical history.
If you completed an initial ketamine series and are noticing symptoms returning, or if you are simply wondering whether maintenance therapy might be the right next step for you, we invite you to reach out to us directly. Contact our team to schedule a consultation, and let us help you figure out together what your next chapter of care should look like. We are here, and we are ready to help you keep moving forward.
